Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs Pfizer Inc (PFE) Price & Performance

Indivior Pharmaceuticals Inc. Common StockTrade
Pfizer IncTrade

Price performance (Past 24H)

Key statistics

Indivior Pharmaceuticals Inc. Common Stock vs Pfizer Inc — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.71 (market cap $4.03B), while Pfizer Inc trades at $29.65 (market cap $166.49B). The key difference: Pfizer Inc is far larger — about 41.3× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Pfizer Inc pays a 5.89% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Pfizer Inc for 158 Days on average.

INDVPFE
Market Cap
$4.03B$166.49B
Volume
2,781,17139,330,520
Sector
HealthHealth
52-Week High
$41.83$29.21
52-Week Low
$24.09$23.67
Typical Hold Time
0 Days158 Days
Enterprise Value
$4.32B$217.98B
Dividend Yield
—5.89%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Indivior Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Pfizer Inc

Pfizer (PFE) trades at $28.37, down slightly by 0.11% on the day, with a bullish technical signal from moving averages. The company maintains strong profitability with a 73.18% gross margin and has beaten earnings estimates for three consecutive quarters. Recent news highlights Pfizer's focus on obesity and oncology pipeline developments, positioning for a catalyst-rich 2026.

Pfizer presents a mixed outlook with stable revenue around $63B but declining net income projections for 2026. The stock trades near analyst consensus target of $29.17, offering modest upside potential. Key risks include patent cliffs and competitive pressures, while the dividend yield and pipeline progress provide defensive appeal for income-focused investors.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INDV
100% Buy0% Sell
Avg holding period · 0 Days
PFE
88% Buy12% Sell
Avg holding period · 158 Days

Top news

Latest headlines on both assets

About Indivior Pharmaceuticals Inc. Common Stock

Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.

Read more on INDV →

About Pfizer Inc

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.

Read more on PFE →